KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $22.7 million.

  • Medpace Holdings' Cash from Financing Activities rose 11348.03% to $22.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$860.4 million, marking a year-over-year decrease of 45866.09%. This contributed to the annual value of -$860.4 million for FY2025, which is 45866.09% down from last year.
  • Per Medpace Holdings' latest filing, its Cash from Financing Activities stood at $22.7 million for Q4 2025, which was up 11348.03% from $3.4 million recorded in Q3 2025.
  • Medpace Holdings' 5-year Cash from Financing Activities high stood at $22.7 million for Q4 2025, and its period low was -$540.6 million during Q2 2025.
  • Over the past 5 years, Medpace Holdings' median Cash from Financing Activities value was -$50.0 million (recorded in 2021), while the average stood at -$100.9 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first skyrocketed by 12250.46% in 2021, then tumbled by 8126576.58% in 2025.
  • Medpace Holdings' Cash from Financing Activities (Quarter) stood at $2.4 million in 2021, then tumbled by 5493.71% to -$131.1 million in 2022, then soared by 101.16% to $1.5 million in 2023, then crashed by 11170.85% to -$168.6 million in 2024, then soared by 113.48% to $22.7 million in 2025.
  • Its Cash from Financing Activities was $22.7 million in Q4 2025, compared to $3.4 million in Q3 2025 and -$540.6 million in Q2 2025.